Robeautè, a Paris, France-based medtech startup developing neurosurgical microrobots, raised $28M in funding.
The round was led by Plural, Cherry Ventures and Kindred Ventures. Other investors included LocalGlobe, Think.Health, APEX Ventures and Brainlab.
The company intends to use the funds to support its entrance into the US where it will pursue FDA approval before addressing the European regulatory authorities.
Led by CEO Bertrand Duplat and COO Joana Cartocci, Robeauté is a medtech startup developing neurosurgical microrobots that can move along curved routes through the extracellular matrix to safely reach multiple sites of interest and carry out whichever task is required locally. The devices can also embark on specific missions depending on the pathology, making them the ideal tool to deliver molecules, implant an electrode and collect cell or live-data samples through sensors to transform our understanding and ability to treat neuropathologies.
FinSMEs
14/01/2025